Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02169024
Other study ID # 1304011772
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2014
Est. completion date December 2017

Study information

Verified date May 2020
Source Yale University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study addresses the intractable challenges of adverse birth outcomes, including preterm delivery and low birthweight, by proposing the development, implementation and evaluation of a model of group prenatal care that could be scaled nationally. Group prenatal care models have been demonstrated through rigorous research to provide significantly improved birth outcomes with implications for maternal-child health and substantial cost savings. However, group prenatal care is currently available to only a small fraction of the more than four million women who give birth annually in the US. Through the development, implementation and evaluation of a new model of group prenatal care, we will create an outcomes-focused model of group prenatal care that will be scalable nationally with an eye toward improving US birth outcomes.

The long-term objective of the proposed study is to reduce the risk for adverse perinatal outcomes during and after pregnancy among women and families receiving prenatal care in health centers in 3 geographic locations serving vulnerable populations: Hidalgo County Texas, Nashville Tennessee, and Detroit Michigan. We will develop, disseminate, and evaluate a new and improved model of group prenatal care, "Expect with Me," based on our previous research on group models of prenatal care, which has already yielded favorable behavioral and biological results in two randomized controlled trials.

We hypothesize that, relative to women who receive standard individual prenatal care, the women who receive "Expect with Me" group prenatal care will be significantly more likely to:

1. have better perinatal outcomes, including better health behaviors during pregnancy (e.g., nutrition, physical activity), better birth outcomes (e.g., decreased preterm labor, low birthweight, Neonatal Intensive Care Unit stays), and better postpartum indicators (e.g., increased breastfeeding);

2. report greater change in risk-related behaviors and psychosocial characteristics that could be considered potential mechanisms for the program's effectiveness;

3. have lower rates of sexually transmitted diseases and rapid repeat pregnancy one year postpartum;

4. have lower healthcare costs through improved outcomes (e.g., appropriate care utilization, fewer complications, reduced NICU admissions/length of stays)

Comparisons based on propensity-score matched sample of women receiving standard individual prenatal care at the same clinical sites.


Description:

This study addresses the intractable challenges of adverse birth outcomes, including preterm delivery and low birthweight, by proposing the development, implementation and evaluation of a model of group prenatal care that could be scaled nationally. Group prenatal care models have been demonstrated through rigorous research to provide significantly improved birth outcomes with implications for maternal-child health and substantial cost savings. However, group prenatal care is currently available to only a small fraction of the more than four million women who give birth annually in the US. Through the development, implementation and evaluation of a new model of group prenatal care, we will create an outcomes-focused model of group prenatal care that will be scalable nationally with an eye toward improving US birth outcomes.

Specific Aims:

The long-term objective of the proposed study is to reduce the risk for adverse perinatal outcomes during and after pregnancy among women and families receiving prenatal care in health centers in 3 geographic locations serving vulnerable populations: Hidalgo County Texas, Nashville Tennessee, and Detroit Michigan. We will develop, disseminate, and evaluate a new and improved model of group prenatal care, "Expect with Me," based on our previous research on group models of prenatal care, which has already yielded favorable behavioral and biological results in two randomized controlled trials. The overall objective of this project is to improve maternal health and reduce adverse birth outcomes. We will meet this objective by achieving three specific goals:

1. Develop a new and improved model of group prenatal care, including curriculum, training materials, IT infrastructure and marketing materials to support broad adoption of group prenatal care, enhance consumer experience, monitor patient outcomes, and ensure national scalability.

2. Implement group prenatal care in three communities at high risk for adverse perinatal outcomes (Hidalgo County TX, Nashville TN, Detroit MI), engaging and training providers in group facilitation and the established curriculum, engaging patients through improved in-reach and outreach strategies, and implementing IT infrastructure to improve uptake, patient experience, and sustainability through the monitoring of patient outcomes.

3. Evaluate the effect of implementing group prenatal care through a rigorous process and outcome evaluation that identifies any barriers to national scalability and examines maternal health and birth outcomes and resultant cost implications.

Specific Study Hypotheses

We hypothesize that, relative to women who receive standard individual prenatal care, the women who receive "Expect with Me" group prenatal care will be significantly more likely to:

1. have better perinatal outcomes, including better health behaviors during pregnancy (e.g., nutrition, physical activity), better birth outcomes (e.g., decreased preterm labor, low birthweight, Neonatal Intensive Care Unit stays), and better postpartum indicators (e.g., increased breastfeeding);

2. report greater change in risk-related behaviors and psychosocial characteristics that could be considered potential mechanisms for the program's effectiveness;

3. have lower rates of sexually transmitted diseases and rapid repeat pregnancy one year postpartum;

4. have lower healthcare costs through improved outcomes (e.g., appropriate care utilization, fewer complications, reduced NICU admissions/length of stays)


Recruitment information / eligibility

Status Completed
Enrollment 2402
Est. completion date December 2017
Est. primary completion date December 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- less than 24 weeks pregnant

- able to attend groups conducted in English or Spanish

- consent to share their data with the study

Exclusion Criteria:

- severe medical problem requiring individual care only, as determined by the participating clinical practice

Study Design


Intervention

Behavioral:
Expect With Me group prenatal care
Expect With Me group prenatal care was designed based on: principles of group care; evidence from RCTs demonstrating improved birth outcomes; ACOG clinical guidelines; and research on patient and provider engagement through technology. Designed with national dissemination as a primary consideration, Expect With Me incorporates best evidence-based aspects of existing models of group care, with a novel IT platform to improve patient engagement and support, enhance health behaviors and decision making, connect providers and patients, and improve health service delivery. Expect With Me provides care to groups of 8-12 women of the same gestational age, implemented after initial individual assessment through delivery. Group visits are 90-120 minutes each, and follow a structured curriculum that incorporates standard content of prenatal care, and emphasizes critical health issues relevant to pregnancy, such as nutrition, physical activity, stress/mental health and sexual health.
Other:
Standard individual prenatal care
Standard of care- individual prenatal care

Locations

Country Name City State
United States Wayne State University Detroit Michigan
United States Vanderbilt University Medical Center Nashville Tennessee

Sponsors (2)

Lead Sponsor Collaborator
Yale University United Health Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other nurse visitation participation in a nurse visitation program 2nd and 3rd trimester of pregnancy
Other sexual debut age at first intercourse 2nd trimester pregnancy
Other living situation where and with whom they live with and the stability of their housing 2nd and 3rd trimester and 6 and 12 months postpartum
Other transfer of motivation relation of motivation for self and baby's health 2nd and3rd trimester and 6 and 12 months postpartum
Other confidence in parenting skills confidence in parenting skills 6 and 12 months postpartum
Other intimate partner violence perpetration and victimization of violence by an intimate partner measured at 2nd and 3rd trimester and 6 and 12 months postpartum
Other perceived stress stress level as reported by patient 2nd and 3rd trimester and 6 and 12 months postpartum
Other depressive symptomatology patient endorsement of depressive symptoms 2nd and 3rd trimester of pregnancy
Other perceived discrimination patient experiences of discrimination 2nd and 3rd trimester of pregnancy and 6 and 12 months postpartum
Other resilience shift and persist scale 2nd and 3rd trimester of pregnancy and 6 and 12 months postpartum
Primary Risk of preterm birth incidence Incidence risk of delivery before 37 weeks gestation up to 37 weeks gestation
Primary Risk of low birth weight incidence Incidence risk of infant weight at birth < 2500 grams delivery
Primary Risk of small for gestational age incidence Incidence risk of infant weight below the 10th percentile for the gestational age at birth delivery
Primary Risk of neonatal intensive care unit (NICU) admission incidence Incidence risk of being admitted to the neonatal intensive care unit (NICU) at birth birth
Secondary breastfeeding initiation and duration of breastfeeding 6 and 12 months postpartum
Secondary nutrition nutritional choices, food security, and use of mindful eating practices 2nd and 3rd trimester of pregnancy and 6 and 12 months postpartum
Secondary physical activity level of physical activity in a typical week 2nd and 3rd trimester and 6 and 12 months postpartum
Secondary readiness for labor and delivery readiness for labor and delivery measured at 2nd and third trimester
Secondary readiness for taking care of baby readiness for taking care of baby 2nd and 3rd trimester of pregnancy
Secondary social support multidimensional scale of perceived social support subscale 2nd and 3rd trimester and 6 and 12 months postpartum
Secondary condom use self-efficacy condom use self efficacy scale 2nd and 3rd trimester and 6 and 12 months postpartum
Secondary substance use use of cigarettes, alcohol, and drugs 2nd and 3rd trimester and 6 and 12 months postpartum
Secondary care satisfaction satisfaction with Expect With Me group prenatal care and use of program components 3rd trimester
Secondary adherence to medical recommendations adherence to medical recommendations (e.g., 6-week postpartum check, pediatric visits, vaccinations, infant feeding) 6 & 12 months postpartum
Secondary postpartum body mass index individual's body weight divided by the square of their height (kg/m2) measured at 6 and 12 months postpartum
Secondary maternal weight gain weight gain as compared to medical recommendations measured at 2nd and 3rd trimester and birth
Secondary mode of delivery mode of delivery (e.g., cesarean, vaginal) delivery
Secondary sexual risk: condom use condom use percent (0-100%) measured at 2nd and 3rd trimester and 6 and 12 months postpartum
Secondary sexual risk: contraceptive use (LARC) use of other contraceptives to prevent pregnancy (no/yes) measured at 2nd and 3rd trimester and 6 and 12 months postpartum
Secondary sexual risk: number of sexual partners number of partners measured at 2nd and 3rd trimester and 6 and 12 months postpartum
Secondary sexual risk: sexually transmitted infection sexually transmitted infection (no/yes, during pregnancy or incident postpartum) measured at 2nd and 3rd trimester and 6 and 12 months postpartum
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Completed NCT02566005 - A Randomized Comparison of Transcervical Foley Bulb With Vaginal Misoprostol to Vaginal Misoprostol Alone for Induction of Labor N/A